Claudio Morales-Perez, a protein production scientist at Generate:Biomedicines, with one of the company's four cryogenic electron microscopes (Studio Nouveau, Lara Woolfson)
Exclusive: The secret to designing protein drugs with AI? Generate believes it's cryo-EM at unprecedented scale
One of the leading biotech companies using artificial intelligence to design protein-based drugs is betting that success lies not in more computing power, but in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
